Advertisement

Topics

Insys Files for Chapter 11 After Fines

02:36 EDT 14 Jun 2019 | CHEManager

The growing US opioid crisis has claimed its first corporate victim. Drugmaker Insys Therapeutics filed for Chapter 11 bankruptcy protection last week, a few days after pleading guilty to federal fraud charges and agreeing to pay $225 million to settle allegations tied to its fentanyl-based painkiller Subsys.

Original Article: Insys Files for Chapter 11 After Fines

NEXT ARTICLE

More From BioPortfolio on "Insys Files for Chapter 11 After Fines"

Advertisement
Quick Search
Advertisement
Advertisement